Comparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes
D-cycloserine (DCS) has been used for decades to treat Mycobacterium tuberculosis (Mtb) but resistance is rarely observed in clinical isolates. Here, the authors report ultra-low rate of emergence of resistance mutations as the underlying mechanism of DCS resistance evasion in Mtb.
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cd1574c81b52465e9b1150a6fda379b5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:cd1574c81b52465e9b1150a6fda379b5 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:cd1574c81b52465e9b1150a6fda379b52021-12-02T16:58:02ZComparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes10.1038/s41467-019-12074-z2041-1723https://doaj.org/article/cd1574c81b52465e9b1150a6fda379b52019-09-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-12074-zhttps://doaj.org/toc/2041-1723D-cycloserine (DCS) has been used for decades to treat Mycobacterium tuberculosis (Mtb) but resistance is rarely observed in clinical isolates. Here, the authors report ultra-low rate of emergence of resistance mutations as the underlying mechanism of DCS resistance evasion in Mtb.Dimitrios EvangelopoulosGareth A. ProsserAngela RodgersBelinda M. DaggBhagwati KhatriMei Mei HoMaximiliano G. GutierrezTeresa CortesLuiz Pedro S. de CarvalhoNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-11 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Dimitrios Evangelopoulos Gareth A. Prosser Angela Rodgers Belinda M. Dagg Bhagwati Khatri Mei Mei Ho Maximiliano G. Gutierrez Teresa Cortes Luiz Pedro S. de Carvalho Comparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes |
description |
D-cycloserine (DCS) has been used for decades to treat Mycobacterium tuberculosis (Mtb) but resistance is rarely observed in clinical isolates. Here, the authors report ultra-low rate of emergence of resistance mutations as the underlying mechanism of DCS resistance evasion in Mtb. |
format |
article |
author |
Dimitrios Evangelopoulos Gareth A. Prosser Angela Rodgers Belinda M. Dagg Bhagwati Khatri Mei Mei Ho Maximiliano G. Gutierrez Teresa Cortes Luiz Pedro S. de Carvalho |
author_facet |
Dimitrios Evangelopoulos Gareth A. Prosser Angela Rodgers Belinda M. Dagg Bhagwati Khatri Mei Mei Ho Maximiliano G. Gutierrez Teresa Cortes Luiz Pedro S. de Carvalho |
author_sort |
Dimitrios Evangelopoulos |
title |
Comparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes |
title_short |
Comparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes |
title_full |
Comparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes |
title_fullStr |
Comparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes |
title_full_unstemmed |
Comparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes |
title_sort |
comparative fitness analysis of d-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes |
publisher |
Nature Portfolio |
publishDate |
2019 |
url |
https://doaj.org/article/cd1574c81b52465e9b1150a6fda379b5 |
work_keys_str_mv |
AT dimitriosevangelopoulos comparativefitnessanalysisofdcycloserineresistantmutantsrevealsbothfitnessneutralandhighfitnesscostgenotypes AT garethaprosser comparativefitnessanalysisofdcycloserineresistantmutantsrevealsbothfitnessneutralandhighfitnesscostgenotypes AT angelarodgers comparativefitnessanalysisofdcycloserineresistantmutantsrevealsbothfitnessneutralandhighfitnesscostgenotypes AT belindamdagg comparativefitnessanalysisofdcycloserineresistantmutantsrevealsbothfitnessneutralandhighfitnesscostgenotypes AT bhagwatikhatri comparativefitnessanalysisofdcycloserineresistantmutantsrevealsbothfitnessneutralandhighfitnesscostgenotypes AT meimeiho comparativefitnessanalysisofdcycloserineresistantmutantsrevealsbothfitnessneutralandhighfitnesscostgenotypes AT maximilianoggutierrez comparativefitnessanalysisofdcycloserineresistantmutantsrevealsbothfitnessneutralandhighfitnesscostgenotypes AT teresacortes comparativefitnessanalysisofdcycloserineresistantmutantsrevealsbothfitnessneutralandhighfitnesscostgenotypes AT luizpedrosdecarvalho comparativefitnessanalysisofdcycloserineresistantmutantsrevealsbothfitnessneutralandhighfitnesscostgenotypes |
_version_ |
1718382415842377728 |